±³¾°½éÉÜ£º¼±ÐÔ·ÎËðÉË£¨Acutelunginjury,ALI£©ÒýÆð¼±ÐÔºôÎü¾½ÆÈ×ÛºÏÕ÷ÊÇ»úÌå¾ÊÜÑÏÖØµÄ¸ÐȾ¡¢´´ÉË¡¢Ðݿ˺óÒýÆðµÄÒԷβ¿Í¨Í¸ÐÔÔö¼Ó¡¢ºôÎü¾½ÆÈΪÖ÷Òª±íÏÖµÄÁÙ´²Î£ÖØÖ¢£¬¸÷ÖÖÑÏÖØ·ÇÐÄÔ´ÐÔÖ²¡ÒòËØËùµ¼ÖµÄÒÔ¼±ÐÔ½øÐÐÐÔ¼ÓÖØµÄºôÎüÀ§ÄѺÍÄÑÖÎÐÔµÍÑõѪ֢¼²²¡£¬ÖÂËÀÂʸߴï30%¡£µ±Ç°ËÁŰȫÇòµÄÐÂÐ͹Ú×´²¡¶¾·ÎÑ×£¬ÆäÖØÖ¢»¼ÕßÒ²³£·¢Õ¹ÎªARDS¡£Ñ°ÕÒеÄÒ©ÎïºÍÖÎÁưе㣬¶ÔÔçÆÚÔ¤·ÀºÍÖÎÁÆALIÏԵü«ÎªÆÈÇС£
LPSÊÇALIÊ×ÒªµÄÖ²¡Òò×Ó£¬·ÎÄÚÑ×֢ЧӦϸ°û£¨ÈçÖÐÐÔÁ£Ï¸°û¡¢µ¥ºË¾ÞÊÉϸ°û£©½éµ¼·Î΢Ѫ¹Üͨ͸ÐÔÔö¸ß¡¢·ÎË®Öײ¢·¢¼±ÐÔºôÎü¹¦ÄÜË¥½ßÊǼ±ÐÔ·ÎËðÉ˵IJ¡Àí»ù´¡¡£
Ó¦Ó÷½Ïò£ººôÎüϵͳÏà¹Ø¿ÎÌâ¡£
¹Ø¼ü´Ê£º¼±ÐÔ·ÎËðÉË¡¢ALI¡¢Acutelunginjury
ʵÑ鶯Î´óÊóƷϵ£ºSD¡¢Wistar£»Ð¡ÊóƷϵ£ºC57BL/6¡¢BALB/C£»ÖÜÁ䣺6-8ÖÜ£»ÐÔ±ð²»ÏÞ¡£
ÔìÄ£·½·¨£º´óÊ󾯸¹ÜµÎ×¢LPS¹¹½¨¼±ÐÔ·ÎËðÉËÄ£ÐÍ¡£
Ä£ÐÍÑéÖ¤£º¶ÔÕÕ×é´óÊóÖ§Æø¹Ü½á¹¹»ù±¾ÍêÕû£¬·ÎѪ¹Ü±Úδ¼ûÃ÷ÏÔÔöºñ£¬·ÎÅݽṹ»ù±¾ÍêÕû£¬Î´¼ûÑ×ÐÔϸ°û½þÈó£»Ä£ÐÍ×é¿É¼û·ÎÅÝÇ»¼°·Î¼äÖÊÃÖÂþÐÔÑ×ϸ°û½þÈ󣬷ÎÅݼä¸ôÔö¿í£¬²¿·ÖÇøÓò·ÎÅݸô¶ÏÁÑ£¬·ÎÅÝήÏÝ¡¢ÉõÖÁ½á¹¹Ïûʧ£¬²¿·Ö·ÎÅÝ´ú³¥ÐÔÆøÖס£
²Î¿¼ÎÄÏ×£ºZhuWenliang,etal.miR-142-5pEncapsulatedbySerum-Derived
ExtracellularVesiclesProtectsagainstAcuteLungInjuryinSepticRatsfollowing
RemoteIschemicPreconditioningviathePTEN/PI3K/AktAxis.[J]JInnateImmun,
2022,undefined:1-11.£¨IF=4.932£©
ÆäËû¼ì²â£ºÈç»îÌå·Î¹¦Äܼì²â£»ÀëÌå·Î×é֯ʪ¸É±ÈÖØ£¨W/D£©¼ì²âµÈ¡£
ʵÑéÍâ°ü ÏëÁ˽â¸ü¶àÇë¹Ø×¢£º